Vincent WACHER,J. Blair WEST,Michael KALEKO,Christian FURLAN FREGUIA
申请号：
US16037612
公开号：
US20180326018A1
申请日:
2018.07.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides, in part, formulations comprising an alkaline phosphatase (AP)-based agent. Particularly, modified-release powder formulations comprising an AP-based agent are provided which release a substantial amount of the AP-based agent in the intestines. Therapeutic uses of the formulations are also provided.
